Related Experiment Video
Updated: Apr 26, 2026

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
Published on: January 28, 2019
A proposed framework for evaluating and comparing efficacy estimates in clinical trials of new rotavirus vaccines
Kathleen M Neuzil1, K Zaman2, John C Victor1
1PATH, Seattle, WA, USA.
Abstract:
Oral rotavirus vaccines have yielded different point estimates of efficacy when tested in different populations. While population and environmental factors may account for these differences, study design characteristics should also be considered. We review the study design elements of rotavirus vaccine trials that may affect point estimates of efficacy, and propose a framework for evaluating new rotavirus vaccines.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Bioequivalence studies: Biowaivers
Clinical Trials
There are four phases in a clinical trial. A phase one...
Bioequivalence Data: Statistical Interpretation
Equivalence: In Vitro and In Vivo Bioequivalence

